Experiments for taxon Cestrum nocturnum (SOLANACEAE)

Experiments (134 results)

Filters
Worktypes (21)
41
31
30
28
25
20
20
20
20
20
19
9
6
6
4
4
3
2
2
1
1
No match
Pharmacology (34)
30
13
9
6
5
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
31
No match
Compounds (26)
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
79
No match
Organisms (22)
28
21
21
14
10
9
6
5
3
2
2
2
2
1
1
1
1
1
1
1
1
1
No match
134 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
1060108
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Cestrum nocturnum (SOLANACEAE)
294841
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-I-[BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R)
1060115
PHARMACOLOGY OF EXTRACT - IN VIVO
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
264296
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5-DIHYDROXY-7-METHOXY: 3-O-[6-O-TRANS-3-5-DIMETHOXY-4-HYDROXY-CINNAMOYL-BETA-D-GLUCOPYRANOSYL] (1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
264314
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
264307
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
947761
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294830
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
PREGN-5-EN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-16-BETA-[[4(R)-5-(BETA-D-GLUCOPYRANOSYL-OXY)-4-METHYL-1-OXO
175903
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
CESTERNOSIDE A
264299
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5'DIHYDROXY-7-METHOXY: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
1240817
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
HYPOTHERMIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264304
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
975665
ISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
TIGOGENIN
1060112
PHARMACOLOGY OF EXTRACT - IN VIVO
INOTROPIC EFFECT NEGATIVE
Cestrum nocturnum (SOLANACEAE)
1240806
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)
Cestrum nocturnum (SOLANACEAE)
294834
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY}: 25(R):
1010764
PHARMACOLOGY OF EXTRACT - IN VITRO
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
1240810
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294826
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
FUROST-5-EN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY-22-ALPHA-METHOXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
1240813
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIFERTILITY
SPERMICIDAL EFFECT
Cestrum nocturnum (SOLANACEAE)
264300
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5'DIHYDROXY-7-METHOXY: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
294829
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FUROSTA-5-20(22)-DIEN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
294831
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
PREGN-5-EN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-16-BETA-[[4(R)-5-(BETA-D-GLUCOPYRANOSYL-OXY)-4-METHYL-1-OXO
1240802
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1010757
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Cestrum nocturnum (SOLANACEAE)
1060104
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Cestrum nocturnum (SOLANACEAE)
891180
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264310
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-15-BETA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
891179
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294842
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,2-ALPHA-17-ALPHA-DIHYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIE: 25(R):
294837
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY]: 25(R):
1240821
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Cestrum nocturnum (SOLANACEAE)
891174
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1208700
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264321
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
1060116
PHARMACOLOGY OF EXTRACT - IN VIVO
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
1240818
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
ANALGESIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
947764
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264308
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
891173
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1240807
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1240809
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1060109
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT NEGATIVE
Cestrum nocturnum (SOLANACEAE)
294840
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-I-[BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R)
264297
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5-DIHYDROXY-7-METHOXY: 3-O-[6-O-TRANS-3-5-DIMETHOXY-4-HYDROXY-CINNAMOYL-BETA-D-GLUCOPYRANOSYL] (1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
1082267
PHARMACOLOGY - EFFECT ON PLANTS
PLANT GERMINATION INHIBITION
Cestrum nocturnum (SOLANACEAE)
1010762
PHARMACOLOGY OF EXTRACT - IN VITRO
TACHYCARDIA ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264318
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
1060111
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1010763
PHARMACOLOGY OF EXTRACT - IN VITRO
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
891177
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1128695
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
ABORTIFACIENT EFFECT
Cestrum nocturnum (SOLANACEAE)
264303
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
1128693
VOUCHER SPECIMEN REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
294827
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
FUROST-5-EN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY-22-ALPHA-METHOXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
264317
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
294838
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
PREGN-5-ENE-20-CARBOXYLIC ACID-GAMMA-LACTONE,2-ALPHA-16-BETA-DIHYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
1240820
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
DIURETIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264313
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
1208701
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1240814
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIFERTILITY
SEMEN COAGULATION
Cestrum nocturnum (SOLANACEAE)
1240803
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
947760
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1208698
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1060105
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Cestrum nocturnum (SOLANACEAE)
121883
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
NOCTURNOSIDE A
264309
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
294839
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
PREGN-5-ENE-20-CARBOXYLIC ACID-GAMMA-LACTONE,2-ALPHA-16-BETA-DIHYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
1060114
PHARMACOLOGY OF EXTRACT - IN VIVO
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
1272232
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264320
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
1240808
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294824
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,24(S)-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(S):
1082266
PHARMACOLOGY - EFFECT ON PLANTS
PLANT GERMINATION INHIBITION
Cestrum nocturnum (SOLANACEAE)
498358
MEDICINAL FOLKLORE REPORTED FOR
ANTIVENIN EFFECT
Cestrum nocturnum (SOLANACEAE)
264295
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5-DIHYDROXY-7-METHOXY: 3-O-[6-O-TRANS-3-5-DIMETHOXY-4-HYDROXY-CINNAMOYL-BETA-D-GLUCOPYRANOSYL] (1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
1208702
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Cestrum nocturnum (SOLANACEAE)
891172
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
947763
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1128694
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
ABORTIFACIENT EFFECT
Cestrum nocturnum (SOLANACEAE)
1240819
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
ANTICONVULSANT ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294832
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
PREGNA-5-16-DIEN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
264319
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
294843
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,2-ALPHA-17-ALPHA-DIHYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIE: 25(R):
1060117
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Cestrum nocturnum (SOLANACEAE)
177320
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
NOCTURONOSIDE B
294828
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
FUROSTA-5-20(22)-DIEN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
264298
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
FLAVONOL,4'-5'DIHYDROXY-7-METHOXY: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-O-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GLUCOPYRANOSIDE
1010761
PHARMACOLOGY OF EXTRACT - IN VITRO
TACHYCARDIA ACTIVITY
Cestrum nocturnum (SOLANACEAE)
891176
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1010758
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Cestrum nocturnum (SOLANACEAE)
153077
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
CESTERNOSIDE B
1060106
PHARMACOLOGY OF EXTRACT - IN VIVO
RESPIRATORY STIMULANT EFFECT
Cestrum nocturnum (SOLANACEAE)
264302
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
264316
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE 25(R):
1060110
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT NEGATIVE
Cestrum nocturnum (SOLANACEAE)
1240804
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294835
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY}: 25(R):
1208699
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTILEUCORRHEA ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1240815
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
HYPOGLYCEMIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
264312
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-15-BETA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
264306
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
294833
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
PREGNA-5-16-DIEN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
498359
MEDICINAL FOLKLORE REPORTED FOR
DIGESTANT ACTION
Cestrum nocturnum (SOLANACEAE)
264315
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
1060113
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294836
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY]: 25(R):
1240805
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
947762
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
891171
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1272233
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1010760
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1240816
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Cestrum nocturnum (SOLANACEAE)
264301
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
1240801
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
TOXICITY ASSESSMENT(QUANTITATIVE)
Cestrum nocturnum (SOLANACEAE)
891178
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Cestrum nocturnum (SOLANACEAE)
1010759
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Cestrum nocturnum (SOLANACEAE)
1240812
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)
294823
VOUCHER SPECIMEN REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
1240811
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Cestrum nocturnum (SOLANACEAE)
175904
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Cestrum nocturnum (SOLANACEAE)
CESTERNOSIDE B
1010765
PHARMACOLOGY OF EXTRACT - IN SITU
ARRHYTHMOGENIC EFFECT
Cestrum nocturnum (SOLANACEAE)
153076
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
CESTERNOSIDE A
1092617
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY(PLANT PATHOGENS)
Cestrum nocturnum (SOLANACEAE)
1060107
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Cestrum nocturnum (SOLANACEAE)
264305
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
264294
VOUCHER SPECIMEN REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
947759
VOUCHER SPECIMEN REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
1177144
PHARMACOLOGY - EFFECT ON PLANTS
PHYTOTOXIC EFFECT
Cestrum nocturnum (SOLANACEAE)
294825
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-YL,24(S)-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(S):
264311
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Cestrum nocturnum (SOLANACEAE)
SPIROST-5-EN-3-BETA-OL,2-ALPHA-15-BETA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):
901728
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Cestrum nocturnum (SOLANACEAE)
O
1082265
PHARMACOLOGY - EFFECT ON PLANTS
PLANT GERMINATION INHIBITION
Cestrum nocturnum (SOLANACEAE)
891175
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cestrum nocturnum (SOLANACEAE)